The University of Chicago Header Logo

Connection

Paul Vezina to Rats, Sprague-Dawley

This is a "connection" page, showing publications Paul Vezina has written about Rats, Sprague-Dawley.
Connection Strength

2.412
  1. Sensitizing exposure to amphetamine increases AMPA receptor phosphorylation without increasing cell surface expression in the rat nucleus accumbens. Neuropharmacology. 2017 05 01; 117:328-337.
    View in: PubMed
    Score: 0.120
  2. Stimuli associated with the presence or absence of amphetamine regulate cytoskeletal signaling and behavior. Eur Neuropsychopharmacol. 2016 11; 26(11):1836-1842.
    View in: PubMed
    Score: 0.117
  3. Drug-Paired Contextual Stimuli Increase Dendritic Spine Dynamics in Select Nucleus Accumbens Neurons. Neuropsychopharmacology. 2016 07; 41(8):2178-87.
    View in: PubMed
    Score: 0.112
  4. Inhibiting cyclin-dependent kinase 5 in the nucleus accumbens enhances the expression of amphetamine-induced locomotor conditioning. Behav Brain Res. 2014 Dec 15; 275:96-100.
    View in: PubMed
    Score: 0.101
  5. Locomotor conditioning by amphetamine requires cyclin-dependent kinase 5 signaling in the nucleus accumbens. Neuropharmacology. 2014 Oct; 85:243-52.
    View in: PubMed
    Score: 0.099
  6. Persistent reversal of enhanced amphetamine intake by transient CaMKII inhibition. J Neurosci. 2013 Jan 23; 33(4):1411-6.
    View in: PubMed
    Score: 0.090
  7. Intermittent nicotine exposure upregulates nAChRs in VTA dopamine neurons and sensitises locomotor responding to the drug. Eur J Neurosci. 2013 Mar; 37(6):1004-11.
    View in: PubMed
    Score: 0.090
  8. Unpredictable saccharin reinforcement enhances locomotor responding to amphetamine. Behav Brain Res. 2012 Jan 01; 226(1):340-4.
    View in: PubMed
    Score: 0.082
  9. Casein kinase 1 enables nucleus accumbens amphetamine-induced locomotion by regulating AMPA receptor phosphorylation. J Neurochem. 2011 Jul; 118(2):237-47.
    View in: PubMed
    Score: 0.081
  10. Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine. J Pharmacol Exp Ther. 2011 Jun; 337(3):724-33.
    View in: PubMed
    Score: 0.079
  11. Transient viral-mediated overexpression of alpha-calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell leads to long-lasting functional upregulation of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors: dopamine type-1 receptor and protein kinase A dependence. Eur J Neurosci. 2010 Apr; 31(7):1243-51.
    View in: PubMed
    Score: 0.074
  12. Transient overexpression of alpha-Ca2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamine. J Neurosci. 2010 Jan 20; 30(3):939-49.
    View in: PubMed
    Score: 0.073
  13. The PKC inhibitor Ro31-8220 blocks acute amphetamine-induced dopamine overflow in the nucleus accumbens. Neurosci Lett. 2009 May 15; 455(2):88-92.
    View in: PubMed
    Score: 0.069
  14. Amphetamine-induced changes in dendritic morphology in rat forebrain correspond to associative drug conditioning rather than nonassociative drug sensitization. Biol Psychiatry. 2009 May 15; 65(10):835-40.
    View in: PubMed
    Score: 0.069
  15. Appetitive sensitization by amphetamine does not reduce its ability to produce conditioned taste aversion to saccharin. Behav Brain Res. 2006 Dec 15; 175(2):305-14.
    View in: PubMed
    Score: 0.058
  16. Blockade of group II metabotropic glutamate receptors in the nucleus accumbens produces hyperlocomotion in rats previously exposed to amphetamine. Neuropharmacology. 2006 Oct; 51(5):986-92.
    View in: PubMed
    Score: 0.058
  17. Microinjection of CART peptide 55-102 into the nucleus accumbens blocks amphetamine-induced locomotion. Neuropeptides. 2003 Dec; 37(6):369-73.
    View in: PubMed
    Score: 0.048
  18. Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow. Neuropharmacology. 2003 Jan; 44(1):102-10.
    View in: PubMed
    Score: 0.045
  19. Repeated ventral tegmental area amphetamine administration alters dopamine D1 receptor signaling in the nucleus accumbens. Synapse. 2002 Sep 01; 45(3):159-70.
    View in: PubMed
    Score: 0.044
  20. The mGlu2/3 receptor agonist LY379268 blocks the expression of locomotor sensitization by amphetamine. Pharmacol Biochem Behav. 2002 Sep; 73(2):333-7.
    View in: PubMed
    Score: 0.044
  21. Conditioned inhibition of amphetamine sensitization. Neurobiol Learn Mem. 2022 07; 192:107636.
    View in: PubMed
    Score: 0.043
  22. Locomotor response to novelty predicts a rat's propensity to self-administer nicotine. Psychopharmacology (Berl). 2001 Nov; 158(2):175-80.
    View in: PubMed
    Score: 0.041
  23. Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area. Psychopharmacology (Berl). 2000 Aug; 151(2-3):184-91.
    View in: PubMed
    Score: 0.038
  24. Group II, but not group I, metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. Neuropharmacology. 2000 Jul 24; 39(10):1692-9.
    View in: PubMed
    Score: 0.038
  25. The effect of previous exposure to amphetamine on drug-induced locomotion and self-administration of a low dose of the drug. Psychopharmacology (Berl). 1999 Nov; 147(2):125-34.
    View in: PubMed
    Score: 0.036
  26. Mesoaccumbens dopamine and the self-administration of amphetamine. Ann N Y Acad Sci. 1999 Jun 29; 877:820-2.
    View in: PubMed
    Score: 0.035
  27. Blockade of glutamate reuptake in the rat nucleus accumbens increases locomotor activity. Brain Res. 1999 Feb 20; 819(1-2):165-9.
    View in: PubMed
    Score: 0.034
  28. Depletion of dopamine in the nucleus accumbens prevents the generation of locomotion by metabotropic glutamate receptor activation. Brain Res. 1998 Nov 23; 812(1-2):260-4.
    View in: PubMed
    Score: 0.034
  29. Environmental enrichment reverses increased addiction risk caused by prenatal ethanol exposure. Drug Alcohol Depend. 2018 10 01; 191:343-347.
    View in: PubMed
    Score: 0.033
  30. Prenatal ethanol exposure increases risk of psychostimulant addiction. Behav Brain Res. 2019 01 01; 356:51-61.
    View in: PubMed
    Score: 0.033
  31. D1 dopamine receptor blockade prevents the facilitation of amphetamine self-administration induced by prior exposure to the drug. Psychopharmacology (Berl). 1998 Jul; 138(2):159-66.
    View in: PubMed
    Score: 0.033
  32. Metabotropic glutamate receptors are necessary for sensitization by amphetamine. Neuroreport. 1998 Feb 16; 9(3):403-6.
    View in: PubMed
    Score: 0.032
  33. Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. J Pharmacol Exp Ther. 1998 Jan; 284(1):317-22.
    View in: PubMed
    Score: 0.032
  34. The metabotropic glutamate receptor antagonist (RS)-MCPG produces hyperlocomotion in amphetamine pre-exposed rats. Neuropharmacology. 1998; 37(2):189-97.
    View in: PubMed
    Score: 0.032
  35. Activation of metabotropic glutamate receptors in the rat nucleus accumbens increases locomotor activity in a dopamine-dependent manner. J Pharmacol Exp Ther. 1997 Nov; 283(2):962-8.
    View in: PubMed
    Score: 0.031
  36. Leptin in the nucleus accumbens core disrupts acute cocaine effects: Implications for GSK3ß connections. Behav Brain Res. 2018 Jan 30; 337:46-52.
    View in: PubMed
    Score: 0.031
  37. Cocaine inhibits leptin-induced increase of the cocaine- and amphetamine-regulated transcript peptide in the nucleus accumbens in rats. Neuroreport. 2017 Aug 02; 28(11):701-704.
    View in: PubMed
    Score: 0.031
  38. Effects of naltrexone on amphetamine-induced locomotion and rearing: acute and repeated injections. Psychopharmacology (Berl). 1997 Jun; 131(3):230-8.
    View in: PubMed
    Score: 0.031
  39. Predisposition to self-administer amphetamine: the contribution of response to novelty and prior exposure to the drug. Psychopharmacology (Berl). 1997 Feb; 129(3):277-84.
    View in: PubMed
    Score: 0.030
  40. D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J Neurosci. 1996 Apr 01; 16(7):2411-20.
    View in: PubMed
    Score: 0.028
  41. Excitatory synaptic function and plasticity is persistently altered in ventral tegmental area dopamine neurons after prenatal ethanol exposure. Neuropsychopharmacology. 2015 Mar; 40(4):893-905.
    View in: PubMed
    Score: 0.025
  42. Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J Pharmacol Exp Ther. 1994 Aug; 270(2):690-6.
    View in: PubMed
    Score: 0.025
  43. Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens. Synapse. 1994 Feb; 16(2):104-12.
    View in: PubMed
    Score: 0.024
  44. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res. 1993 Mar 12; 605(2):332-7.
    View in: PubMed
    Score: 0.023
  45. a-1 Adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission. Neuropsychopharmacology. 2012 Aug; 37(9):2161-72.
    View in: PubMed
    Score: 0.022
  46. Nicotinic excitation of serotonergic projections from dorsal raphe to the nucleus accumbens. J Neurophysiol. 2011 Aug; 106(2):801-8.
    View in: PubMed
    Score: 0.020
  47. Blockade of group II, but not group I, mGluRs in the rat nucleus accumbens inhibits the expression of conditioned hyperactivity in an amphetamine-associated environment. Behav Brain Res. 2008 Aug 05; 191(1):62-6.
    View in: PubMed
    Score: 0.016
  48. Enhanced nicotinic receptor function and drug abuse vulnerability. J Neurosci. 2007 Aug 15; 27(33):8771-8.
    View in: PubMed
    Score: 0.015
  49. Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci. 1994 Mar 01; 6(3):293-8.
    View in: PubMed
    Score: 0.006
  50. Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the rat. Neurosci Lett. 1994 Feb 28; 168(1-2):111-4.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.